spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  HALO90 

 HSMN NewsFeed - 17 May 2012
Covidien Introduces HALO90 ULTRA Ablation Catheter for Treatment of Barrett’s Esophagus
Devices Gastroenterology
 HSMN NewsFeed - 21 Nov 2011
BARRX Medical, Inc. Announces Definitive Agreement to be Acquired by Covidien
Devices Mergers & Acquisitions
 HSMN NewsFeed - 21 Nov 2011
Covidien Announces Definitive Agreement to Acquire BÂRRX Medical, Inc.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 10 Mar 2011
Practice Guidelines Confirm Utility of Endoscopic Radiofrequency Ablation (RFA) for the Treatment of Barrett's Esophagus
Devices Gastroenterology
 HSMN NewsFeed - 7 Sep 2010
BARRX Medical Signs Distribution Agreement With Medico's Hirata for Exclusive Distribution of the HALO Radiofrequency Ablation System in Japan
Devices Gastroenterology Distribution
 HSMN NewsFeed - 3 Mar 2010
FDA Provides 510k Clearance for BARRX Medical's HALO90 Ablation Catheter for the Treatment of Radiation Proctitis and Gastric Antral Vascular Ectasia (GAVE)
Devices Gastroenterology FDA
 HSMN NewsFeed - 21 Jul 2008
Precancerous Esophagus Disease Eliminated in 98.4% of Patients Treated With HALO Ablation System
Devices Gastroenterology
 HSMN NewsFeed - 19 May 2008
Presentation of Landmark Clinical Trial Evaluating Endoscopic Treatment for Pre-cancerous Condition of Esophagus
Devices Gastroenterology
 HSMN NewsFeed - 15 May 2008
New Study Reports That Ablative Therapy With HALO360 Device Effectively Treats Highest-Risk Category of Barrett's Esophagus
Devices Gastroenterology
 HSMN NewsFeed - 20 May 2007
Presentation of Long-term Results for Treating Barrett's Esophagus with HALO Ablation System
Devices Gastroenterology
 HSMN NewsFeed - 15 May 2007
Genetic Abnormalities Associated With Esophageal Cancer Eliminated After Treatment With HALO Ablation System
Devices Gastroenterology
 HSMN NewsFeed - 5 Feb 2007
Study Reports 70% of Barrett's Esophagus Patients Cured at One-Year Follow-Up in Multi-Center Study
Devices
 HSMN NewsFeed - 20 Jul 2006
BARRX Medical, Inc. Secures $27.8 Million Series C Venture Funding
Devices Venture Capital
 HSMN NewsFeed - 23 May 2006
Nine Clinical Studies Evaluating Safety and Efficacy of HALO360 and HALO90 Systems to Treat Barrett's Esophagus Presented at Digestive Disease Week
Devices Gastroenterology
Return to NewsFeed  

 Additional items found! 2

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 2 additional stories matching:
HALO90
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.